BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 23, 2018
View Archived Issues
Merck & Co. identifies novel IDO-1 inhibitors
Read More
Processa Pharmaceuticals assigned license for CTP-499
Read More
DiscGenics studies IDCT in patients with symptomatic lumbar intervertebral disc degeneration
Read More
New phase II trial explores SAR-440340 alone and with dupilumab for moderate to severe asthma
Read More
SemaThera signs financing and licensing deal for ST-102
Read More
Zhejiang Hisun Pharmaceutical identifies new anti-HBV compounds
Read More
Discovery of novel potent BRAF inhibitor for the treatment of cancer
Read More
EMA reports negative CHMP assessment for abaloparatide-SC
Read More
Roche describes new TLR7 agonists and HBsAg secretion inhibitors
Read More
Novel PD-1/PD-L1 interaction inhibitors derived at Polaris Pharmaceuticals
Read More
Ohio State University, Georgia State University patent antiparasitic compounds
Read More
CARB-X and Shionogi partner to develop a novel antibiotic
Read More
OP-1074, a new candidate for ER-positive breast cancer
Read More
Soligenix receives E.U. orphan designation for RiVax
Read More
Argenx expands pipeline with ARGX-117 for autoimmune diseases
Read More
Lokelma receives E.U. approval for hyperkalemia
Read More
TSP5 linked to bladder cancer progression and survival
Read More
Galafold approved in Japan for Fabry disease
Read More
AZD-0364 demonstrates efficacy in preclinical models of NSCLC
Read More
EMA committee hands down positive opinion for Cabometyx
Read More
Ozempic approved in Japan
Read More
Japanese orphan drug designation awarded to gilteritinib for FLT3 mutation-positive AML
Read More
Dracen Pharmaceuticals receives investment for immuno-metabolism agents
Read More
Shingrix obtains approvals in E.U. and Japan
Read More
Annual Drugs to Watch report names 12 new potential blockbuster drugs
Read More
FDA expands Tasigna indications for pediatric patients with CML
Read More
vTv Therapeutics completes phase Ib of Simplici-T1 trial of TTP-399 in type 1 diabetes
Read More
CBT Pharmaceuticals licenses anti-CTLA-4 monoclonal antibody from Crown Bioscience
Read More
First preclinical data presented for VNRX-5133
Read More